Newron Pharmaceuticals
NWRN.SW
#8112
Rank
A$0.33 B
Marketcap
$17.65
Share price
3.45%
Change (1 day)
21.66%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -$1.74

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.74. In 2023 the company made an earnings per share (EPS) of -$1.74 a decrease over its 2022 EPS that were of -$1.71.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-$1.742.03%
2022-$1.7115.39%
2021-$1.48-31.32%
2020-$2.1614.74%
2019-$1.8836.6%
2018-$1.38159.87%
2017-$0.53-67.81%
2016-$1.64-39.24%
2015-$2.71107.61%
2014-$1.3015.8%
2013-$1.13119.91%
2012-$0.51-66.51%
2011-$1.53-71.49%
2010-$5.36-10.83%
2009-$6.0142.06%
2008-$4.2356.53%
2007-$2.70-52.84%
2006-$5.73-188.53%
2005$6.47